Hypertension, or high blood pressure, is one of the most common cardiovascular conditions affecting millions of people worldwide. If left uncontrolled, it can lead to serious complications such as heart attack, stroke, and kidney damage. Effective blood pressure management is crucial to prevent these life-threatening outcomes.
NEBIVALVE AM, formulated by Steris Healthcare Pvt. Ltd., is a potent combination tablet containing Nebivolol 5 mg and S-Amlodipine 2.5 mg. This dual-action formulation is designed to provide comprehensive control of blood pressure by combining the benefits of a beta-blocker with a calcium channel blocker. It is ideal for patients who require enhanced blood pressure control or are not achieving adequate results with monotherapy.
Composition and Mechanism of Action
Nebivolol 5 mg
Nebivolol is a third-generation beta-1 selective beta-blocker that works by reducing heart rate and cardiac output. Additionally, it promotes nitric oxide-mediated vasodilation, which relaxes blood vessels and improves overall blood flow. This mechanism helps in lowering blood pressure without compromising cardiac efficiency.
S-Amlodipine 2.5 mg
S-Amlodipine is the active enantiomer of amlodipine, a calcium channel blocker. It selectively inhibits calcium ion influx in vascular smooth muscle cells, resulting in arterial dilation. This reduces systemic vascular resistance and effectively lowers blood pressure, while also minimizing edema and other side effects associated with conventional amlodipine.
Synergistic Effect
The combination of Nebivolol and S-Amlodipine provides dual benefits:
Reduces cardiac workload and heart rate (Nebivolol)
Relaxes blood vessels and decreases vascular resistance (S-Amlodipine)
This synergistic effect ensures fast and sustained blood pressure control and improves overall cardiovascular health.
Uses of NEBIVALVE AM
NEBIVALVE AM is prescribed for a variety of cardiovascular conditions, including:
Essential Hypertension: To control high blood pressure effectively.
Cardiovascular Risk Reduction: Helps in preventing heart attack and stroke in high-risk patients.
Patients Not Controlled by Monotherapy: Ideal for individuals who need combination therapy for optimal blood pressure management.
Angina Management (off-label use): May provide additional benefits in selected patients with stable angina.
Benefits of NEBIVALVE AM
1. Dual Mechanism for Superior Blood Pressure Control
Combining Nebivolol and S-Amlodipine addresses both cardiac output and vascular resistance, achieving more stable blood pressure levels.
2. Improved Endothelial Function
Nebivolol enhances nitric oxide availability, promoting vascular health and reducing arterial stiffness.
3. Fewer Side Effects
S-Amlodipine, as the active enantiomer, is associated with lower incidence of peripheral edema, a common side effect of conventional calcium channel blockers.
4. Once-Daily Convenience
The formulation supports once-daily dosing, improving patient compliance and adherence.
5. Cardiovascular Protection
Beyond blood pressure control, NEBIVALVE AM contributes to heart health by reducing strain on the heart and improving overall vascular function.
Dosage and Administration
Recommended Dose: One tablet of NEBIVALVE AM once daily, preferably at the same time each day.
Administration: Can be taken with or without food. Swallow the tablet whole with water.
Individualization: Dosage may vary depending on patient response, severity of hypertension, and tolerability.
Important: Always follow the prescribing physician’s instructions and do not self-adjust the dose.
Side Effects
NEBIVALVE AM is generally well tolerated. Some patients may experience mild side effects, including:
Dizziness or lightheadedness
Fatigue or tiredness
Headache
Palpitations
Flushing or mild swelling of extremities
Serious Side Effects (Rare)
Severe hypotension
Bradycardia (abnormally low heart rate)
Shortness of breath in patients with pre-existing cardiac conditions
Allergic reactions such as rash or swelling
Consult your healthcare provider immediately if you experience severe or persistent side effects.
Precautions and Warnings
Heart Conditions: Caution in patients with bradycardia, heart block, or severe heart failure.
Diabetes: Monitor blood sugar levels, as beta-blockers may mask hypoglycemia symptoms.
Pregnancy and Breastfeeding: Use only if prescribed by a doctor.
Kidney and Liver Disorders: Dose adjustment may be necessary.
Drug Interactions: Inform your physician about other medications, particularly other antihypertensives, antiarrhythmics, or CYP3A4 inhibitors.
Lifestyle Measures: Continue a heart-healthy diet, regular exercise, and routine monitoring of blood pressure.
Conclusion
NEBIVALVE AM, formulated by Steris Healthcare Pvt. Ltd., is a high-quality, dual-action therapy for effective blood pressure management. With Nebivolol 5 mg and S-Amlodipine 2.5 mg, it combines beta-blockade and calcium channel inhibition for superior cardiovascular protection, better blood pressure control, and improved patient compliance.
Ideal for patients requiring combination therapy, NEBIVALVE AM not only helps in controlling hypertension but also supports long-term heart health. When taken as prescribed under medical supervision, it provides a reliable solution for achieving optimal blood pressure control and reducing cardiovascular risk.
